The stock of Cesca Therapeutics Inc (NASDAQ:KOOL) is a huge mover today! About 288,019 shares traded hands. Cesca Therapeutics Inc (NASDAQ:KOOL) has declined 9.67% since April 20, 2016 and is downtrending. It has underperformed by 14.22% the S&P500.
The move comes after 5 months positive chart setup for the $30.09 million company. It was reported on Nov, 22 by Barchart.com. We have $3.43 PT which if reached, will make NASDAQ:KOOL worth $1.20M more.
Cesca Therapeutics Inc (NASDAQ:KOOL) Ratings Coverage
Out of 2 analysts covering Cesca Therapeutics (NASDAQ:KOOL), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. Cesca Therapeutics has been the topic of 4 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The company was upgraded on Tuesday, August 25 by Zacks. Maxim Group downgraded Cesca Therapeutics Inc (NASDAQ:KOOL) on Tuesday, December 22 to “Hold” rating. The firm has “Buy” rating by H.C. Wainwright given on Monday, September 21. The stock has “Buy” rating given by Maxim Group on Tuesday, November 17.
According to Zacks Investment Research, “Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.”
More notable recent Cesca Therapeutics Inc (NASDAQ:KOOL) news were published by: Bizjournals.com which released: “Cesca Therapeutics shares jump on positive results from clinical study” on August 03, 2016, also Bizjournals.com with their article: “Shares of Rancho Cordova-based Cesca Therapeutics jump 27 percent in a day” published on October 24, 2016, Globenewswire.com published: “Cesca Therapeutics Granted Third U.S. Patent Relating to Its Proprietary …” on October 18, 2016. More interesting news about Cesca Therapeutics Inc (NASDAQ:KOOL) were released by: Marketwatch.com and their article: “/quotes/zigman/3870025/realtime” published on November 09, 2010 as well as Globenewswire.com‘s news article titled: “Cesca Therapeutics to Announce First Quarter Fiscal 2017 Results on November …” with publication date: November 16, 2016.
KOOL Company Profile
Cesca Therapeutics Inc., incorporated on July 3, 1986, is clinical-stage biotechnology company. The Firm develops and markets integrated cellular therapies and delivery systems. The Firm is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Firm focuses on the business of research, development and commercialization of autologous cell therapeutics for use in the regenerative medicine industry.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.